Marjan Boerma
Concepts (459)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart | 30 | 2023 | 361 | 8.990 |
Why?
| Radiation Injuries | 17 | 2024 | 153 | 3.810 |
Why?
| Radiation Injuries, Experimental | 15 | 2016 | 105 | 3.650 |
Why?
| Oxygen | 12 | 2023 | 361 | 3.130 |
Why?
| Protons | 5 | 2023 | 81 | 2.880 |
Why?
| Heart Diseases | 9 | 2023 | 239 | 2.850 |
Why?
| Myocardium | 15 | 2021 | 443 | 2.600 |
Why?
| Cosmic Radiation | 8 | 2023 | 38 | 2.510 |
Why?
| Radiation-Protective Agents | 14 | 2021 | 116 | 2.470 |
Why?
| Animals | 89 | 2023 | 14409 | 2.110 |
Why?
| Tocotrienols | 7 | 2019 | 42 | 1.940 |
Why?
| Space Flight | 7 | 2021 | 37 | 1.800 |
Why?
| Rats | 33 | 2023 | 3419 | 1.790 |
Why?
| Mitochondria, Heart | 4 | 2018 | 42 | 1.680 |
Why?
| Oxidative Stress | 15 | 2020 | 958 | 1.410 |
Why?
| Radiation, Ionizing | 9 | 2021 | 120 | 1.390 |
Why?
| Mast Cells | 8 | 2014 | 64 | 1.360 |
Why?
| Mice, Inbred C57BL | 27 | 2022 | 2001 | 1.340 |
Why?
| Intestine, Small | 5 | 2021 | 123 | 1.340 |
Why?
| Mice | 43 | 2023 | 6428 | 1.250 |
Why?
| Pyrroles | 4 | 2016 | 78 | 1.150 |
Why?
| Rats, Sprague-Dawley | 18 | 2020 | 1664 | 1.090 |
Why?
| Protein C | 3 | 2023 | 23 | 1.050 |
Why?
| Male | 56 | 2023 | 27347 | 1.030 |
Why?
| Gamma Rays | 4 | 2020 | 56 | 1.030 |
Why?
| Radiation Protection | 3 | 2021 | 55 | 1.020 |
Why?
| DNA Methylation | 4 | 2019 | 575 | 1.010 |
Why?
| Intestines | 7 | 2021 | 204 | 0.990 |
Why?
| Hippocampus | 7 | 2021 | 242 | 0.980 |
Why?
| Dose-Response Relationship, Radiation | 14 | 2023 | 204 | 0.890 |
Why?
| Cone-Beam Computed Tomography | 2 | 2022 | 34 | 0.870 |
Why?
| Astronauts | 2 | 2024 | 5 | 0.850 |
Why?
| Oxygen Radioisotopes | 2 | 2019 | 16 | 0.840 |
Why?
| Biology | 1 | 2021 | 9 | 0.840 |
Why?
| Radiation Tolerance | 3 | 2014 | 87 | 0.820 |
Why?
| Endothelial Cells | 8 | 2023 | 294 | 0.810 |
Why?
| Radiobiology | 3 | 2021 | 20 | 0.810 |
Why?
| Immunomodulation | 1 | 2021 | 42 | 0.810 |
Why?
| Weightlessness Simulation | 2 | 2020 | 23 | 0.790 |
Why?
| Pentoxifylline | 2 | 2013 | 19 | 0.790 |
Why?
| Environmental Pollution | 1 | 2021 | 11 | 0.780 |
Why?
| Skin | 4 | 2021 | 469 | 0.750 |
Why?
| Vitamin E | 6 | 2021 | 107 | 0.750 |
Why?
| Aorta, Abdominal | 1 | 2020 | 45 | 0.730 |
Why?
| Gene Expression Regulation | 7 | 2021 | 1063 | 0.700 |
Why?
| Ions | 4 | 2023 | 38 | 0.670 |
Why?
| Models, Animal | 8 | 2022 | 255 | 0.670 |
Why?
| Receptor, Bradykinin B2 | 2 | 2015 | 9 | 0.650 |
Why?
| Heptanoic Acids | 3 | 2008 | 39 | 0.630 |
Why?
| Mitochondria | 4 | 2020 | 490 | 0.620 |
Why?
| Radiotherapy, Image-Guided | 3 | 2016 | 25 | 0.620 |
Why?
| Myocarditis | 2 | 2021 | 45 | 0.610 |
Why?
| Glutathione Transferase | 2 | 2015 | 178 | 0.600 |
Why?
| Thioctic Acid | 1 | 2017 | 3 | 0.600 |
Why?
| Palladium | 1 | 2017 | 5 | 0.600 |
Why?
| Radiation Dosage | 7 | 2021 | 170 | 0.600 |
Why?
| Gene-Environment Interaction | 1 | 2017 | 44 | 0.590 |
Why?
| Neoplasms | 5 | 2021 | 1322 | 0.580 |
Why?
| Intestinal Mucosa | 9 | 2021 | 259 | 0.580 |
Why?
| Organometallic Compounds | 1 | 2017 | 47 | 0.580 |
Why?
| Whole-Body Irradiation | 9 | 2021 | 161 | 0.560 |
Why?
| Leadership | 1 | 2017 | 114 | 0.550 |
Why?
| Humans | 40 | 2024 | 54391 | 0.530 |
Why?
| Hematopoietic Stem Cells | 4 | 2017 | 215 | 0.500 |
Why?
| Capsaicin | 1 | 2014 | 17 | 0.480 |
Why?
| Sensory Receptor Cells | 1 | 2014 | 14 | 0.480 |
Why?
| Gene Deletion | 1 | 2015 | 293 | 0.480 |
Why?
| Neurons, Afferent | 1 | 2014 | 35 | 0.480 |
Why?
| Radiotherapy | 5 | 2015 | 137 | 0.460 |
Why?
| Indoles | 1 | 2016 | 289 | 0.460 |
Why?
| Disease Models, Animal | 7 | 2021 | 1647 | 0.450 |
Why?
| Transforming Growth Factor beta1 | 1 | 2013 | 66 | 0.450 |
Why?
| Kininogens | 1 | 2012 | 4 | 0.440 |
Why?
| Kallikrein-Kinin System | 1 | 2012 | 4 | 0.440 |
Why?
| X-Rays | 4 | 2022 | 57 | 0.440 |
Why?
| Thoracic Neoplasms | 1 | 2012 | 11 | 0.430 |
Why?
| Naphthalenes | 1 | 2013 | 126 | 0.430 |
Why?
| Behavior, Animal | 5 | 2021 | 202 | 0.420 |
Why?
| Pyridines | 1 | 2013 | 137 | 0.420 |
Why?
| Signal Transduction | 3 | 2021 | 1752 | 0.420 |
Why?
| Cognition | 3 | 2019 | 350 | 0.400 |
Why?
| Fibroblasts | 3 | 2015 | 386 | 0.400 |
Why?
| Intestinal Diseases | 2 | 2007 | 36 | 0.380 |
Why?
| Methionine | 4 | 2020 | 146 | 0.380 |
Why?
| Up-Regulation | 5 | 2016 | 509 | 0.370 |
Why?
| Apoptosis | 9 | 2020 | 1302 | 0.370 |
Why?
| Antigens, Differentiation, Myelomonocytic | 3 | 2017 | 46 | 0.370 |
Why?
| Gene Expression | 7 | 2019 | 664 | 0.370 |
Why?
| Chromans | 3 | 2021 | 62 | 0.370 |
Why?
| Endothelium, Vascular | 4 | 2010 | 288 | 0.360 |
Why?
| NF-E2-Related Factor 2 | 3 | 2020 | 63 | 0.350 |
Why?
| Isothiocyanates | 2 | 2020 | 25 | 0.340 |
Why?
| rho-Associated Kinases | 1 | 2008 | 20 | 0.340 |
Why?
| Antigens, CD | 3 | 2017 | 242 | 0.340 |
Why?
| Receptor, Endothelin A | 1 | 2008 | 8 | 0.340 |
Why?
| Gene Expression Profiling | 5 | 2018 | 1141 | 0.330 |
Why?
| alpha-Tocopherol | 1 | 2008 | 10 | 0.330 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2008 | 150 | 0.320 |
Why?
| Dendritic Spines | 5 | 2019 | 21 | 0.320 |
Why?
| Hydrogen | 2 | 2018 | 13 | 0.320 |
Why?
| Interleukin-11 | 1 | 2007 | 9 | 0.310 |
Why?
| Chromosome Aberrations | 2 | 2022 | 316 | 0.310 |
Why?
| Solar Activity | 2 | 2018 | 8 | 0.300 |
Why?
| Sulfonamides | 1 | 2008 | 146 | 0.300 |
Why?
| Dendrites | 2 | 2017 | 28 | 0.290 |
Why?
| Sulfhydryl Compounds | 1 | 2006 | 19 | 0.290 |
Why?
| Protein Kinase Inhibitors | 1 | 2008 | 216 | 0.290 |
Why?
| Female | 17 | 2023 | 28471 | 0.290 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 474 | 0.290 |
Why?
| Cells, Cultured | 7 | 2016 | 1737 | 0.280 |
Why?
| Coronary Circulation | 1 | 2006 | 62 | 0.280 |
Why?
| Heart Rate | 3 | 2021 | 358 | 0.280 |
Why?
| Adenosine | 1 | 2006 | 71 | 0.270 |
Why?
| Myocytes, Cardiac | 2 | 2018 | 137 | 0.270 |
Why?
| Dietary Supplements | 2 | 2020 | 457 | 0.270 |
Why?
| Myocardial Contraction | 1 | 2006 | 116 | 0.270 |
Why?
| Immunohistochemistry | 3 | 2021 | 1090 | 0.270 |
Why?
| Collagen | 4 | 2021 | 223 | 0.270 |
Why?
| Homocysteine | 1 | 2006 | 126 | 0.270 |
Why?
| Mitochondrial Membrane Transport Proteins | 2 | 2016 | 23 | 0.260 |
Why?
| Vasodilation | 1 | 2006 | 106 | 0.260 |
Why?
| Fibrosis | 4 | 2021 | 209 | 0.260 |
Why?
| Cell Respiration | 2 | 2015 | 51 | 0.250 |
Why?
| Jejunum | 3 | 2021 | 56 | 0.250 |
Why?
| Neurons | 2 | 2018 | 486 | 0.240 |
Why?
| von Willebrand Factor | 1 | 2004 | 53 | 0.240 |
Why?
| Heart Transplantation | 1 | 2007 | 307 | 0.240 |
Why?
| Maze Learning | 2 | 2021 | 55 | 0.240 |
Why?
| Biological Factors | 1 | 2023 | 13 | 0.230 |
Why?
| Heart Atria | 1 | 2023 | 57 | 0.230 |
Why?
| Sulfoxides | 2 | 2020 | 28 | 0.230 |
Why?
| DNA Damage | 4 | 2016 | 357 | 0.230 |
Why?
| Blood Cells | 4 | 2021 | 58 | 0.230 |
Why?
| Bone Marrow Cells | 4 | 2017 | 232 | 0.230 |
Why?
| Thrombomodulin | 3 | 2015 | 41 | 0.230 |
Why?
| Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 55 | 0.230 |
Why?
| Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 55 | 0.220 |
Why?
| Heart Ventricles | 2 | 2017 | 271 | 0.220 |
Why?
| Weightlessness | 2 | 2020 | 14 | 0.220 |
Why?
| Reproducibility of Results | 2 | 2023 | 1301 | 0.210 |
Why?
| Rabbits | 1 | 2023 | 425 | 0.210 |
Why?
| Editorial Policies | 1 | 2021 | 11 | 0.210 |
Why?
| Mammalian orthoreovirus 3 | 1 | 2021 | 13 | 0.210 |
Why?
| Capsid Proteins | 1 | 2021 | 24 | 0.210 |
Why?
| Reoviridae Infections | 1 | 2021 | 21 | 0.200 |
Why?
| Proteome | 2 | 2020 | 178 | 0.200 |
Why?
| Duodenum | 1 | 2021 | 36 | 0.200 |
Why?
| Lymphocytes | 1 | 2022 | 168 | 0.200 |
Why?
| Carrier Proteins | 2 | 2013 | 360 | 0.200 |
Why?
| Ventricular Remodeling | 2 | 2016 | 65 | 0.200 |
Why?
| Inflammation | 4 | 2023 | 678 | 0.200 |
Why?
| Immunoblotting | 1 | 2021 | 134 | 0.200 |
Why?
| Phosphorylation | 2 | 2013 | 613 | 0.200 |
Why?
| Ileum | 1 | 2021 | 103 | 0.190 |
Why?
| Metabolome | 2 | 2023 | 109 | 0.190 |
Why?
| Cell Count | 2 | 2013 | 181 | 0.190 |
Why?
| Carbon | 2 | 2019 | 61 | 0.190 |
Why?
| Rats, Long-Evans | 1 | 2020 | 29 | 0.190 |
Why?
| Thymus Gland | 1 | 2020 | 45 | 0.190 |
Why?
| Gastrointestinal Tract | 2 | 2020 | 136 | 0.190 |
Why?
| Blood-Brain Barrier | 1 | 2020 | 59 | 0.190 |
Why?
| Insulin-Like Growth Factor I | 1 | 2021 | 137 | 0.190 |
Why?
| Somatostatin | 2 | 2011 | 26 | 0.190 |
Why?
| Cytokines | 4 | 2018 | 677 | 0.190 |
Why?
| Abdomen | 1 | 2020 | 84 | 0.180 |
Why?
| Fluorouracil | 2 | 2017 | 61 | 0.180 |
Why?
| Epigenesis, Genetic | 3 | 2022 | 399 | 0.180 |
Why?
| Research Design | 1 | 2022 | 375 | 0.180 |
Why?
| Linear Energy Transfer | 2 | 2017 | 17 | 0.180 |
Why?
| Adaptation, Ocular | 1 | 2019 | 4 | 0.180 |
Why?
| Blood-Retinal Barrier | 1 | 2019 | 6 | 0.180 |
Why?
| Genotype | 1 | 2021 | 600 | 0.180 |
Why?
| Spleen | 1 | 2020 | 187 | 0.180 |
Why?
| Hematopoiesis | 2 | 2021 | 80 | 0.180 |
Why?
| Gravity, Altered | 1 | 2018 | 3 | 0.170 |
Why?
| Thrombosis | 1 | 2021 | 243 | 0.170 |
Why?
| Macrophages | 2 | 2014 | 404 | 0.170 |
Why?
| Doxorubicin | 2 | 2018 | 259 | 0.170 |
Why?
| Social Behavior | 1 | 2019 | 83 | 0.160 |
Why?
| Wound Healing | 3 | 2009 | 228 | 0.160 |
Why?
| Retina | 1 | 2018 | 65 | 0.160 |
Why?
| Antioxidants | 2 | 2017 | 297 | 0.160 |
Why?
| Enzymes | 1 | 2017 | 31 | 0.150 |
Why?
| Tissue Fixation | 1 | 2017 | 35 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 674 | 0.150 |
Why?
| Metagenome | 1 | 2017 | 44 | 0.150 |
Why?
| Graft Survival | 2 | 2009 | 165 | 0.150 |
Why?
| Neuronal Plasticity | 1 | 2017 | 58 | 0.150 |
Why?
| Staining and Labeling | 1 | 2017 | 106 | 0.150 |
Why?
| Memory, Short-Term | 1 | 2017 | 85 | 0.150 |
Why?
| Diastole | 2 | 2008 | 79 | 0.150 |
Why?
| Simvastatin | 2 | 2007 | 35 | 0.150 |
Why?
| Administration, Oral | 2 | 2018 | 461 | 0.140 |
Why?
| Schools, Pharmacy | 1 | 2017 | 68 | 0.140 |
Why?
| Stem Cells | 1 | 2017 | 194 | 0.140 |
Why?
| Transforming Growth Factor beta | 2 | 2007 | 158 | 0.140 |
Why?
| Time Factors | 4 | 2019 | 3210 | 0.140 |
Why?
| Heavy Ions | 1 | 2015 | 17 | 0.140 |
Why?
| Radiotherapy, Conformal | 1 | 2016 | 55 | 0.140 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 41 | 0.140 |
Why?
| Fellowships and Scholarships | 1 | 2017 | 117 | 0.140 |
Why?
| RNA, Messenger | 4 | 2020 | 1203 | 0.140 |
Why?
| Liver | 4 | 2018 | 1226 | 0.130 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 206 | 0.130 |
Why?
| Aging | 2 | 2023 | 784 | 0.130 |
Why?
| Obesity | 3 | 2019 | 1203 | 0.130 |
Why?
| Embryo, Mammalian | 1 | 2015 | 69 | 0.130 |
Why?
| Cell Death | 1 | 2016 | 223 | 0.130 |
Why?
| Polymerase Chain Reaction | 2 | 2008 | 531 | 0.130 |
Why?
| Troponin I | 1 | 2015 | 20 | 0.130 |
Why?
| Echocardiography | 2 | 2018 | 392 | 0.130 |
Why?
| Sequence Analysis, DNA | 1 | 2016 | 274 | 0.130 |
Why?
| Immunosuppressive Agents | 1 | 2016 | 248 | 0.120 |
Why?
| Carbon Tetrachloride | 1 | 2014 | 20 | 0.120 |
Why?
| MAP Kinase Signaling System | 2 | 2012 | 133 | 0.120 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2014 | 6 | 0.120 |
Why?
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2014 | 8 | 0.120 |
Why?
| Denervation | 1 | 2014 | 21 | 0.120 |
Why?
| Membrane Potential, Mitochondrial | 1 | 2014 | 48 | 0.120 |
Why?
| Infant | 1 | 2023 | 3829 | 0.120 |
Why?
| Body Weight | 3 | 2021 | 578 | 0.120 |
Why?
| CCAAT-Enhancer-Binding Protein-delta | 1 | 2014 | 25 | 0.120 |
Why?
| Cardiac Output | 1 | 2014 | 50 | 0.120 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 73 | 0.120 |
Why?
| Protein Kinase C-alpha | 1 | 2013 | 11 | 0.120 |
Why?
| Protein Conformation | 1 | 2014 | 226 | 0.120 |
Why?
| Bone Marrow Transplantation | 1 | 2014 | 149 | 0.110 |
Why?
| Aldehydes | 1 | 2013 | 97 | 0.110 |
Why?
| Organ Size | 1 | 2014 | 237 | 0.110 |
Why?
| Cardiovascular System | 1 | 2013 | 50 | 0.110 |
Why?
| Protein Binding | 4 | 2021 | 736 | 0.110 |
Why?
| Lung | 2 | 2014 | 508 | 0.110 |
Why?
| Organs at Risk | 1 | 2013 | 70 | 0.110 |
Why?
| Cell Survival | 1 | 2015 | 657 | 0.110 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 158 | 0.110 |
Why?
| Drug Interactions | 1 | 2013 | 206 | 0.110 |
Why?
| Mitochondrial Swelling | 1 | 2012 | 5 | 0.110 |
Why?
| Rats, Inbred BN | 1 | 2012 | 21 | 0.110 |
Why?
| Pancreas | 2 | 2011 | 80 | 0.110 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2013 | 176 | 0.110 |
Why?
| Radiation | 1 | 2012 | 17 | 0.110 |
Why?
| Mass Media | 1 | 2012 | 22 | 0.110 |
Why?
| Dose-Response Relationship, Drug | 3 | 2020 | 1476 | 0.110 |
Why?
| Endothelin-1 | 1 | 2012 | 30 | 0.110 |
Why?
| Hypertension, Pulmonary | 1 | 2014 | 126 | 0.110 |
Why?
| Blood Cell Count | 3 | 2017 | 43 | 0.100 |
Why?
| Brain | 1 | 2020 | 1392 | 0.100 |
Why?
| Liver Cirrhosis | 1 | 2014 | 218 | 0.100 |
Why?
| Environmental Exposure | 1 | 2013 | 205 | 0.100 |
Why?
| Research | 1 | 2012 | 117 | 0.100 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1060 | 0.100 |
Why?
| Blotting, Western | 1 | 2012 | 684 | 0.100 |
Why?
| Receptor, PAR-2 | 1 | 2010 | 6 | 0.100 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 476 | 0.100 |
Why?
| DNA | 2 | 2024 | 581 | 0.090 |
Why?
| Cell Cycle | 2 | 2016 | 275 | 0.090 |
Why?
| Metabolomics | 2 | 2023 | 149 | 0.090 |
Why?
| Cell Line | 2 | 2015 | 1152 | 0.090 |
Why?
| DNA Repair | 2 | 2016 | 203 | 0.090 |
Why?
| Leukocytes | 1 | 2010 | 86 | 0.090 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 151 | 0.090 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 60 | 0.090 |
Why?
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 10 | 0.090 |
Why?
| Immunity, Innate | 1 | 2010 | 114 | 0.090 |
Why?
| Random Allocation | 4 | 2010 | 312 | 0.090 |
Why?
| Skin Transplantation | 1 | 2009 | 50 | 0.080 |
Why?
| Collagen Type III | 1 | 2008 | 10 | 0.080 |
Why?
| Receptors, AMPA | 2 | 2019 | 17 | 0.080 |
Why?
| Microarray Analysis | 1 | 2008 | 85 | 0.080 |
Why?
| Muscle, Smooth | 1 | 2008 | 68 | 0.080 |
Why?
| Cytoskeleton | 1 | 2008 | 50 | 0.080 |
Why?
| Dentate Gyrus | 2 | 2019 | 17 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 232 | 0.080 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 104 | 0.080 |
Why?
| Synapses | 2 | 2019 | 90 | 0.080 |
Why?
| Collagen Type I | 1 | 2008 | 97 | 0.080 |
Why?
| Transcription, Genetic | 2 | 2010 | 418 | 0.080 |
Why?
| Hypolipidemic Agents | 1 | 2007 | 33 | 0.080 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2019 | 121 | 0.080 |
Why?
| Transplantation, Heterotopic | 1 | 2007 | 6 | 0.080 |
Why?
| Connective Tissue | 1 | 2006 | 23 | 0.070 |
Why?
| Ileostomy | 1 | 2006 | 7 | 0.070 |
Why?
| Amino Acid Sequence | 1 | 2008 | 767 | 0.070 |
Why?
| Tight Junctions | 2 | 2019 | 28 | 0.070 |
Why?
| Orchiectomy | 1 | 2006 | 38 | 0.070 |
Why?
| Atropine | 1 | 2006 | 31 | 0.070 |
Why?
| Mevalonic Acid | 1 | 2006 | 7 | 0.070 |
Why?
| C-Reactive Protein | 1 | 2007 | 159 | 0.070 |
Why?
| Muscle Tonus | 1 | 2006 | 21 | 0.070 |
Why?
| Nifedipine | 1 | 2006 | 24 | 0.070 |
Why?
| Theophylline | 1 | 2006 | 24 | 0.070 |
Why?
| Acetylcholine | 1 | 2006 | 53 | 0.070 |
Why?
| Cell Line, Transformed | 1 | 2006 | 88 | 0.070 |
Why?
| Mice, Knockout | 3 | 2015 | 927 | 0.070 |
Why?
| Proteomics | 2 | 2019 | 343 | 0.070 |
Why?
| Recombinant Proteins | 1 | 2007 | 570 | 0.070 |
Why?
| Calcium Channel Blockers | 1 | 2006 | 72 | 0.070 |
Why?
| Anti-Arrhythmia Agents | 1 | 2006 | 87 | 0.070 |
Why?
| Muscle Contraction | 1 | 2006 | 111 | 0.070 |
Why?
| Vasodilator Agents | 1 | 2006 | 111 | 0.070 |
Why?
| Tenascin | 1 | 2005 | 1 | 0.070 |
Why?
| Genetic Techniques | 1 | 2005 | 15 | 0.070 |
Why?
| DNA-Binding Proteins | 1 | 2008 | 462 | 0.070 |
Why?
| Muscle, Smooth, Vascular | 1 | 2006 | 140 | 0.070 |
Why?
| Nucleic Acid Hybridization | 1 | 2005 | 54 | 0.060 |
Why?
| Ultraviolet Rays | 1 | 2005 | 56 | 0.060 |
Why?
| Reactive Oxygen Species | 2 | 2018 | 491 | 0.060 |
Why?
| DNA, Complementary | 1 | 2005 | 145 | 0.060 |
Why?
| Pressure | 1 | 2005 | 120 | 0.060 |
Why?
| Necrosis | 1 | 2005 | 208 | 0.060 |
Why?
| Oxidation-Reduction | 2 | 2018 | 383 | 0.060 |
Why?
| Stress, Mechanical | 1 | 2005 | 96 | 0.060 |
Why?
| Amifostine | 1 | 2004 | 2 | 0.060 |
Why?
| Endocardium | 1 | 2004 | 6 | 0.060 |
Why?
| Endomyocardial Fibrosis | 1 | 2004 | 3 | 0.060 |
Why?
| Transcription Factors | 1 | 2008 | 622 | 0.060 |
Why?
| Premedication | 1 | 2004 | 18 | 0.060 |
Why?
| Radiometry | 2 | 2016 | 125 | 0.060 |
Why?
| Cellular Microenvironment | 1 | 2024 | 27 | 0.060 |
Why?
| Ventricular Function, Left | 1 | 2005 | 182 | 0.060 |
Why?
| Down-Regulation | 1 | 2005 | 388 | 0.060 |
Why?
| Extracellular Matrix | 1 | 2004 | 111 | 0.060 |
Why?
| Histones | 2 | 2017 | 335 | 0.060 |
Why?
| Lipopolysaccharides | 2 | 2017 | 200 | 0.060 |
Why?
| Toll-Like Receptor 4 | 1 | 2023 | 51 | 0.060 |
Why?
| Electrocardiography | 1 | 2005 | 290 | 0.060 |
Why?
| Radiotherapy Dosage | 2 | 2016 | 245 | 0.050 |
Why?
| Ultracentrifugation | 1 | 2022 | 8 | 0.050 |
Why?
| Cytogenetic Analysis | 1 | 2022 | 90 | 0.050 |
Why?
| Chemokines | 2 | 2014 | 96 | 0.050 |
Why?
| Biological Availability | 2 | 2013 | 131 | 0.050 |
Why?
| Peroxynitrous Acid | 2 | 2013 | 51 | 0.050 |
Why?
| Interleukin-12 | 2 | 2014 | 37 | 0.050 |
Why?
| Coronary Vessels | 1 | 2004 | 197 | 0.050 |
Why?
| Orthoreovirus, Mammalian | 1 | 2021 | 17 | 0.050 |
Why?
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2021 | 53 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Viral Load | 1 | 2021 | 86 | 0.050 |
Why?
| Citrulline | 2 | 2014 | 98 | 0.050 |
Why?
| Breast Neoplasms | 3 | 2018 | 1249 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 106 | 0.050 |
Why?
| NF-kappa B | 1 | 2023 | 336 | 0.050 |
Why?
| Virulence | 1 | 2021 | 196 | 0.050 |
Why?
| Mass Spectrometry | 1 | 2022 | 313 | 0.050 |
Why?
| Organ Specificity | 1 | 2021 | 126 | 0.050 |
Why?
| Catecholamines | 1 | 2020 | 48 | 0.050 |
Why?
| Virus Replication | 1 | 2021 | 143 | 0.050 |
Why?
| Animals, Newborn | 1 | 2021 | 396 | 0.050 |
Why?
| Occupational Exposure | 2 | 2013 | 129 | 0.050 |
Why?
| Biological Transport | 1 | 2020 | 195 | 0.050 |
Why?
| Drinking | 1 | 2020 | 78 | 0.050 |
Why?
| Plasma | 1 | 2020 | 52 | 0.050 |
Why?
| Lipid Metabolism | 1 | 2021 | 194 | 0.040 |
Why?
| Sarcopenia | 1 | 2020 | 83 | 0.040 |
Why?
| Swine | 1 | 2021 | 430 | 0.040 |
Why?
| Zonula Occludens-1 Protein | 1 | 2019 | 7 | 0.040 |
Why?
| DNA, Satellite | 1 | 2019 | 15 | 0.040 |
Why?
| Centromere | 1 | 2019 | 17 | 0.040 |
Why?
| Aquaporin 4 | 1 | 2019 | 9 | 0.040 |
Why?
| Crystallins | 1 | 2019 | 9 | 0.040 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2019 | 37 | 0.040 |
Why?
| Energy Intake | 1 | 2020 | 196 | 0.040 |
Why?
| Eye Proteins | 1 | 2019 | 19 | 0.040 |
Why?
| Stress, Physiological | 1 | 2020 | 194 | 0.040 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 92 | 0.040 |
Why?
| Extraterrestrial Environment | 1 | 2019 | 8 | 0.040 |
Why?
| Protein Subunits | 1 | 2019 | 85 | 0.040 |
Why?
| Cluster Analysis | 1 | 2019 | 249 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2019 | 89 | 0.040 |
Why?
| Retinal Pigment Epithelium | 1 | 2018 | 24 | 0.040 |
Why?
| Anticarcinogenic Agents | 1 | 2018 | 35 | 0.040 |
Why?
| Transcriptome | 1 | 2020 | 346 | 0.040 |
Why?
| Oxidative Phosphorylation | 1 | 2018 | 57 | 0.040 |
Why?
| Drug Synergism | 1 | 2018 | 171 | 0.040 |
Why?
| CA3 Region, Hippocampal | 1 | 2017 | 5 | 0.040 |
Why?
| Carbohydrate Metabolism | 1 | 2017 | 31 | 0.040 |
Why?
| Lipid Peroxidation | 1 | 2018 | 132 | 0.040 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2018 | 219 | 0.040 |
Why?
| CA1 Region, Hippocampal | 1 | 2017 | 28 | 0.040 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 377 | 0.040 |
Why?
| Methylation | 1 | 2017 | 130 | 0.040 |
Why?
| Mammary Neoplasms, Experimental | 1 | 2018 | 135 | 0.040 |
Why?
| Silver Staining | 1 | 2016 | 8 | 0.040 |
Why?
| Survival Analysis | 1 | 2019 | 736 | 0.040 |
Why?
| Stress, Psychological | 1 | 2019 | 270 | 0.040 |
Why?
| Feeding Behavior | 1 | 2018 | 200 | 0.040 |
Why?
| Models, Genetic | 1 | 2017 | 209 | 0.040 |
Why?
| Arkansas | 1 | 2022 | 2100 | 0.030 |
Why?
| DNA Repair Enzymes | 1 | 2016 | 50 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2016 | 78 | 0.030 |
Why?
| Blood Glucose | 1 | 2019 | 489 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 95 | 0.030 |
Why?
| Endothelium | 1 | 2015 | 45 | 0.030 |
Why?
| Flow Cytometry | 1 | 2017 | 547 | 0.030 |
Why?
| Hydroxy Acids | 1 | 2014 | 8 | 0.030 |
Why?
| Myeloid Cells | 1 | 2014 | 38 | 0.030 |
Why?
| Fatty Acids, Unsaturated | 1 | 2014 | 46 | 0.030 |
Why?
| NF-E2 Transcription Factor, p45 Subunit | 1 | 2013 | 4 | 0.030 |
Why?
| Permeability | 1 | 2014 | 87 | 0.030 |
Why?
| Mice, 129 Strain | 1 | 2013 | 49 | 0.030 |
Why?
| Half-Life | 1 | 2013 | 92 | 0.030 |
Why?
| Molecular Dynamics Simulation | 1 | 2013 | 40 | 0.030 |
Why?
| Mitosis | 1 | 2014 | 106 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2014 | 133 | 0.030 |
Why?
| Gene Order | 1 | 2013 | 18 | 0.030 |
Why?
| Interleukin-10 | 1 | 2014 | 106 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 1551 | 0.030 |
Why?
| Rats, Wistar | 1 | 2013 | 237 | 0.030 |
Why?
| Leukocyte Count | 1 | 2013 | 77 | 0.030 |
Why?
| Gene Targeting | 1 | 2013 | 32 | 0.030 |
Why?
| Monte Carlo Method | 1 | 2013 | 99 | 0.030 |
Why?
| Drug Design | 1 | 2013 | 133 | 0.030 |
Why?
| Binding Sites | 1 | 2013 | 440 | 0.030 |
Why?
| Models, Molecular | 1 | 2013 | 423 | 0.030 |
Why?
| Glutathione | 1 | 2013 | 330 | 0.030 |
Why?
| Trypsin | 1 | 2011 | 17 | 0.030 |
Why?
| Interviews as Topic | 1 | 2012 | 314 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2013 | 658 | 0.020 |
Why?
| GTP Cyclohydrolase | 1 | 2010 | 5 | 0.020 |
Why?
| Colony-Forming Units Assay | 1 | 2010 | 31 | 0.020 |
Why?
| Radioactive Fallout | 1 | 2010 | 3 | 0.020 |
Why?
| Nitric Oxide Synthase | 1 | 2010 | 102 | 0.020 |
Why?
| Interferon-gamma | 1 | 2011 | 195 | 0.020 |
Why?
| Deferoxamine | 1 | 2009 | 12 | 0.020 |
Why?
| Pericarditis | 1 | 2010 | 21 | 0.020 |
Why?
| Oligopeptides | 1 | 2010 | 95 | 0.020 |
Why?
| Cesium Radioisotopes | 1 | 2009 | 5 | 0.020 |
Why?
| Hodgkin Disease | 1 | 2010 | 51 | 0.020 |
Why?
| Thermoluminescent Dosimetry | 1 | 2009 | 7 | 0.020 |
Why?
| Chemokine CXCL9 | 1 | 2009 | 10 | 0.020 |
Why?
| Drug Combinations | 1 | 2009 | 128 | 0.020 |
Why?
| Bacterial Translocation | 1 | 2009 | 23 | 0.020 |
Why?
| Forecasting | 1 | 2010 | 161 | 0.020 |
Why?
| Models, Biological | 1 | 2013 | 825 | 0.020 |
Why?
| Keratinocytes | 1 | 2009 | 96 | 0.020 |
Why?
| Interleukin-1beta | 1 | 2009 | 92 | 0.020 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 9 | 0.020 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 72 | 0.020 |
Why?
| Sp1 Transcription Factor | 1 | 2008 | 18 | 0.020 |
Why?
| 14-3-3 Proteins | 1 | 2008 | 24 | 0.020 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 40 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2009 | 318 | 0.020 |
Why?
| Mutation | 1 | 2015 | 1504 | 0.020 |
Why?
| HSP90 Heat-Shock Proteins | 1 | 2008 | 53 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2009 | 514 | 0.020 |
Why?
| Receptors, Thrombin | 1 | 2007 | 16 | 0.020 |
Why?
| Thrombin | 1 | 2007 | 48 | 0.020 |
Why?
| Survival Rate | 1 | 2010 | 954 | 0.020 |
Why?
| Nitric Oxide | 1 | 2009 | 298 | 0.020 |
Why?
| Tissue Plasminogen Activator | 1 | 2008 | 124 | 0.020 |
Why?
| Abdominal Neoplasms | 1 | 2007 | 19 | 0.020 |
Why?
| Pelvic Neoplasms | 1 | 2007 | 20 | 0.020 |
Why?
| Drug Evaluation, Preclinical | 1 | 2007 | 158 | 0.020 |
Why?
| Treatment Outcome | 2 | 2009 | 5612 | 0.020 |
Why?
| Coronary Artery Disease | 1 | 2010 | 329 | 0.020 |
Why?
| Incidence | 1 | 2007 | 1083 | 0.010 |
Why?
| Quality of Life | 1 | 2007 | 924 | 0.010 |
Why?
| Postoperative Complications | 1 | 2006 | 1035 | 0.010 |
Why?
| Risk Factors | 1 | 2006 | 3937 | 0.010 |
Why?
|
|
Boerma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|